Pear Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Pear Therapeutics's balance sheet done over the years? Its assets were worth $95,129,000 last year, which is less than in the previous period. 68% of Pear Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $64,544,000, which means an decrease by -40% compared compared to last year.

Debt to Assets

Pear Therapeutics, Inc. (NASDAQ:PEARW): Debt to assets
2019 109692000 175.73M 160.21%
2020 132366000 314.67M 237.73%
2021 197160000 106.72M 54.13%
2022 95129000 64.54M 67.85%

PEARW Balance Sheet (2019 – 2022)

2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
 48.30M169.56M110.9M27.41M
Short term investments
 10.97M5.00M13.53M77.03M
Net receivables
 6.94M1.79M257K1.00M
Inventory
 69K000
Other current assets
 6.67M8.87M1.36M1.52M
Total current assets
 72.95M185.24M126.05M106.97M
Non-current assets:
Property, Plant and Equipment
 14.95M6.25M4.27M680K
Goodwill
 0000
Intangible assets
 0000
Long term investments
 0000
Other non-current assets
 7.21M5.66M2.03M2.03M
Total non-current assets
 22.17M11.91M6.30M2.71M
Total assets
 95.12M197.16M132.36M109.69M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
 284K421K267K3.63M
Short term debt
 29.43M26.99M26.34M4.44M
Total current liabilities
 49.44M47.16M40.68M17.10M
Non-current liabilities:
Long term debt
 8.17M0010.71M
Deferred tax
 0000
Other non-current liabilities
 6.92M59.56M273.98M526K
Total non-current liabilities
 15.10M59.56M273.98M158.63M
Total liabilities
 64.54M106.72M314.67M175.73M
Data sourceData source